CLINICAL TRIALS PROFILE FOR CEFTAZIDIME
✉ Email this page to a colleague
All Clinical Trials for ceftazidime
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00173901 ↗ | Adverse Drug Reactions of Different Brands of Ceftazidime Injection | Unknown status | National Taiwan University Hospital | Phase 4 | 2001-03-01 | The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug. |
NCT00210964 ↗ | Ceftobiprole in Hospital Acquired Pneumonia | Completed | Basilea Pharmaceutica | Phase 3 | 2005-04-01 | The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril (the water-soluble prodrug [form] of ceftobiprole) referred to as ceftobiprole versus a comparator in the treatment of patients with nosocomial pneumonia. |
NCT00229008 ↗ | Ceftobiprole in Hospital Acquired Pneumonia | Completed | Basilea Pharmaceutica | Phase 3 | 2005-11-01 | The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril (the water-soluble prodrug [form] of ceftobiprole) referred to as ceftobiprole versus a comparator in the treatment of patients with nosocomial pneumonia. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ceftazidime
Condition Name
Clinical Trial Locations for ceftazidime
Trials by Country
Clinical Trial Progress for ceftazidime
Clinical Trial Phase
Clinical Trial Sponsors for ceftazidime
Sponsor Name